The drug of choice for treating a newborn with presumed ductal-dependent cyanotic congenital heart disease is:

Dobutamine

Indomethacin

Prostaglandin E1

Morphine

The drug of choice for treating a newborn with presumed ductal-dependent cyanotic congenital heart disease is Prostaglandin E1
***
Prostaglandin E1 is also known as Alprostadil.
Prostaglandin E1 (PGE1) is used to keep the ductus arteriosus patent and can be life‐saving in neonates with ductal‐dependent cardiac lesions.
****
EMT RESCUE 1122 MCQ